Tech Company Financing Transactions
Paradigm Spine Funding Round
Paradigm Spine, based in New York, raised $75 million from PDL BioPharma.
Transaction Overview
Company Name
Announced On
2/21/2014
Transaction Type
Venture Equity
Amount
$75,000,000
Round
Undisclosed
Investors
PDL BioPharma (John McLaughlin)
Proceeds Purpose
An initial $50 million was provided at the close of the transaction, with the remaining $25 million to be funded in two equal tranches upon achievement of specified milestones. Paradigm will use the proceeds to refinance its existing credit facility and primarily expand its domestic commercial operations.
Company Information
Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
505 Park Ave. 14th Floor
New York, NY 10022
USA
New York, NY 10022
USA
Phone
Website
Email Address
Overview
Paradigm Spine is a provider of non-fusion spinal implant solutions that serve to address the unmet clinical needs of spine surgeons and their patients. Starting with the coflex interspinous implant technology Paradigm Spine develops a full non-fusion product portfolio of motion preserving, tissue sparing technologies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Marc Viscogliosi
Chief Financial Officer
Steve Ward
Chief Technical Officer
Francis Magee
VP - Marketing
Lisa Denison
VP - Sales
Charlie Gilbride
VP - Sales
Timothy Hein
Browse more venture capital transactions:
Prev: 2/21/2014: Cylance venture capital transaction
Next: 2/21/2014: Acompli venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs